Interview with the Co-Founder, Director, President & CEO: OncoSec Medical Incorporated (ONCS)

Healthcare >> CEO Interviews >> July 6, 2015

Punit Dhillon is Co-Founder, Director, President and CEO of OncoSec Medical Incorporated, a biopharmaceutical company developing its advanced-stage immunotherapy to treat solid tumors. He was formerly Vice President of Finance and Operations at Inovio Pharmaceuticals, Inc. In his management experience, Mr. Dhillon has raised over $160 million through multiple financings and several licensing deals, including early-stage deals with Merck and Wyeth. His management experience spans corporate finance, M&A, integration, successful in-licensing of key intellectual property, strategy implementation, corporate transactions, and collaborations with leading universities and working with several key opinion leaders worldwide. Mr. Dhillon is also the Founder of BeCancerPositive.org, an online community where people can share their experiences with cancer and inspire hope for others. Mr. Dhillon holds a Bachelor of Arts with honors in political science and a minor in business administration from Simon Fraser University. Profile

TWST: Can you provide an overview of the company and explain your business model if it is in any way unique?

Mr. Dhillon: OncoSec is a cancer immunotherapy company advancing a leading

Join for free to read a longer excerpt or purchase this article

Interview with the Co-Founder, Director, President & CEO: OncoSec Medical Incorporated (ONCS)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the Co-Founder, Director, President & CEO: OncoSec Medical Incorporated (ONCS)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS